XIFIN has been a leader in Molecular Diagnostics by helping the country’s largest molecular testing laboratories meet their most complex reimbursement challenges.
A proven leader in the Molecular testing market, XIFIN processes over half of all claims submitted by laboratories specializing in molecular testing nationwide, including those from leading companies such as Myriad, US Labs/Esoterix, Clarient, and others.
- We Help You Stay In Front Of Change – Whether it’s managing the typical reimbursement challenges faced by all laboratories, or addressing longstanding difficulties such as modifier and consolidation rules, new payor requirements and split jurisdiction issues, we’ve been on the forefront of these issues and have designed the XIFIN billing system to quickly adjust to the needs of our clients.
- We Help You Adjust To Rapid Growth - Molecular testing capabilities have delivered hyper-growth to many laboratories, leaving these businesses' billing operations overwhelmed by the depth and breadth of the claims volume. XIFIN’s billing system helps high-growth laboratories address this issue by utilizing a sophisticated rules-based workflow to automate the claims process, thus requiring very little manual intervention, and enabling laboratories to more easily scale their billing operations to match their rapid growth.
- Bridge the Gap Between on Premise Software and Outsourced Billing Options – As a response to the unique challenges faced by early stage molecular laboratories, XIFIN has developed a unique hybrid outsourcing solution that is designed to match your laboratory’s needs at every stage of growth.
Our marriage of highly automated, web-based application and outsourced billing services makes it possible to design a mixed in-house and outsourced billing model and to seamlessly adjust the mix as you grow. You determine your level of control, whether it supports an early stage policy of complete billing outsourcing, a revenue optimization strategy through in-house management with a fully staffed billing department, or something in between.
- Consulting Services for Commercialization and Reimbursement Strategies – To successfully bring your new Molecular Diagnostics Concept to market, there are many questions to be answered well in advance of any decisions regarding billing and accounts receivable. XIFIN provides expert professional services to early stage companies to guide them through the complex process of commercialization. XIFIN’s consulting service, led by Rina Wolf, XIFIN's Vice President of Strategic Commercialization, Consulting, and Industry Affairs, will help you gain insights into important critical success factors such as:
- Clinical Utility / Medical Efficacy / Outcomes
- Patient Advocacy Programs
- Removing Reimbursement Barriers to Early Test Adoption
- Coding and Pricing Strategies
- Regulatory and Legislative Environment
Designed around industry best practices, and used to process more than 150 million claims for most of the nation’s largest laboratories, XIFIN has proven to be an important partner in enabling laboratories to automate their billing systems, better manage medical claims filing, and reduce liability risks associated with payor and regulatory compliance.